Indian Journal of Dermatology (Jan 2015)
Omalizumab-A review
Abstract
Omalizumab is a recombinant, humanized, monoclonal antibody against human immunoglobulin E (IgE). The US FDA has approved this molecule for chronic urticaria.
Keywords
Indian Journal of Dermatology (Jan 2015)
Omalizumab is a recombinant, humanized, monoclonal antibody against human immunoglobulin E (IgE). The US FDA has approved this molecule for chronic urticaria.